マーケットレポート詳細

薬局自動化の世界市場:製品別、エンドユーザー別2027年予測

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) - Global Forecast to 2027

出版元:MarketsandMarkets   出版元について
発行年:2022年6月
定価 :Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文250ページになります。
商品コード:MAM2945

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

薬局自動化の世界市場規模は2022年で56億ドル、2027年に82億ドル、市場の平均年成長率は7.9%に到達する見込みです。
レポートは薬局自動化の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測(製品別市場、エンドユーザー別市場)を中心に構成されています。また競合状況、主要企業情報(20社)、ファイブフォース分析、エコシステム分析などの分析も加味し、薬局自動化市場の動向および今後成長性を詳細にレポートしています。

【レポート構成概要】

◆薬局自動化の世界市場予測2020-2027年

・市場規模(US$)

◆製品別、市場-2027年

自動調剤/保管システム
・ロボット/ロボット自動ディスペンシングシステム
・カルーセル
・自動ディスペンシングキャビネット
・一元薬局
・分散薬局
自動包装・ラベリングシステム
自動テーブルトップカウンター
自動医薬品調合システム
その他薬局自動化システム
※(市場規模US$)

◆エンドユーザー別、市場-2027年

入院患者用薬局
・急性期治療システム
・長期療養施設

外来薬局
・外来/ファストトラッククリニック
・病院販売
小売薬局
薬剤給付管理(PBM)組織/通信販売薬局
※(市場規模US$)

◆主要国地域別市場-2027年

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照

◆市場分析

・市場ダイナミクス(ドライバー、障壁、機会、課題)
・ファイブフォース分析
・規制分析
・バリューチェーン分析
・特許分析
・エコシステム分析
・COVID-19の影響
・市場シェア分析
・競合状況

◆薬局自動化の主要企業プロフィール動向

・BECKTON, DICKINSON AND COMPANY
・OMNICELL, INC.
・KUKA AKTIENGESELLSCHAFT (SWISSLOG HEALTHCARE)
・BAXTER INTERNATIONAL INC.
・CAPSA HEALTHCARE
・CERNER CORPORATION
・株式会社湯山製作所
・ARXIUM, INC.
・PARATA SYSTEMS, LLC
・RXSAFE, LLC
・SCRIPTPRO, LLC
・PEARSON MEDICAL TECHNOLOGIES, LLC
・MEDICAL PACKAGING INC., LLC
・TENSION CORPORATION
・NORITSU PHARMACY AUTOMATION
・EUCLID MEDICAL PRODUCTS
・TOUCHPOINT MEDICAL SOLUTIONS
・MEDITECH PHARMACY MANAGEMENT SOLUTIONS
・INNOVATION ASSOCIATES
・MCKESSON CORPORATION

(その他企業)
・WILLACH GROUP: COMPANY OVERVIEW
・STÄUBLI INTERNATIONAL: COMPANY OVERVIEW
・MEDAVAIL: COMPANY OVERVIEW
・PHARMACY AUTOMATION SYSTEM: COMPANY OVERVIEW
・DEENOVA SRL: COMPANY OVERVIEW

(全250頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次)

1      INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION & SCOPE
1.2.1              INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2              MARKET SEGMENTATION
・     FIGURE 1            PHARMACY AUTOMATION MARKET SEGMENTATION
1.2.3              YEARS CONSIDERED FOR THE STUDY
1.3             CURRENCY
・     TABLE 1              EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.4             STAKEHOLDERS
1.5             SUMMARY OF CHANGES

2      RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
・     FIGURE 2            PHARMACY AUTOMATION MARKET: RESEARCH DESIGN
2.1.1              SECONDARY RESEARCH
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY DATA
・     FIGURE 3            PRIMARY SOURCES   28
2.1.2.1            KEY DATA FROM PRIMARY SOURCES
2.1.2.2            INSIGHTS FROM PRIMARY EXPERTS
・     FIGURE 4            BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
・     FIGURE 5            BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2             MARKET SIZE ESTIMATION
・     FIGURE 6            MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
・     FIGURE 7            REVENUE SHARE ANALYSIS ILLUSTRATION
・     FIGURE 8            TOP-DOWN APPROACH   32
・     FIGURE 9            CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・     FIGURE 10          CAGR PROJECTIONS
2.3             DATA TRIANGULATION APPROACH
・     FIGURE 11          DATA TRIANGULATION METHODOLOGY
2.4             MARKET SHARE ESTIMATION
2.5             ASSUMPTIONS FOR THE STUDY
2.6             LIMITATIONS
2.6.1              METHODOLOGY-RELATED LIMITATIONS
2.6.2              SCOPE-RELATED LIMITATIONS

2.7             RISK ASSESSMENT
・     TABLE 2              RISK ASSESSMENT: PHARMACY AUTOMATION MARKET

3      EXECUTIVE SUMMARY

・     FIGURE 12          PHARMACY AUTOMATION MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION)
・     FIGURE 13          AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY TYPE, 2022 VS. 2027 (USD MILLION)
・     FIGURE 14          AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS,
BY APPLICATION/OPERATION, 2022 VS. 2027 (USD MILLION)
・     FIGURE 15          PHARMACY AUTOMATION MARKET, BY END USER,
2022 VS. 2027 (USD MILLION)
・     FIGURE 16          GEOGRAPHICAL SNAPSHOT OF THE PHARMACY AUTOMATION MARKET

4      PREMIUM INSIGHTS

4.1             PHARMACY AUTOMATION MARKET OVERVIEW
・     FIGURE 17          GROWING NEED TO MINIMIZE MEDICATION ERRORS AND REDUCE HEALTHCARE COSTS TO DRIVE MARKET GROWTH
4.2             ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY PRODUCT AND COUNTRY (2021)
・     FIGURE 18          AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS TO DOMINATE THE ASIA PACIFIC MARKET IN 2021
4.3             PHARMACY AUTOMATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・     FIGURE 19          CHINA TO REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD
4.4             PHARMACY AUTOMATION MARKET, BY REGION (2020–2027)
・     FIGURE 20          NORTH AMERICA TO DOMINATE THE PHARMACY AUTOMATION MARKET
IN 2027
4.5             PHARMACY AUTOMATION MARKET: DEVELOPED VS. DEVELOPING MARKETS
・     FIGURE 21          DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES
DURING THE FORECAST PERIOD

5      MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・     FIGURE 22          PHARMACY AUTOMATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1              DRIVERS
5.2.1.1            GROWING NEED TO MINIMIZE MEDICATION ERRORS
5.2.1.2            DECENTRALIZATION OF PHARMACIES
5.2.1.3            RISING GERIATRIC POPULATION LEADING TO INCREASED ADOPTION OF AUTOMATED DISPENSING SYSTEMS
・     FIGURE 23          GLOBAL GERIATRIC POPULATION (65 YEARS & ABOVE), BY REGION
5.2.1.4            GROWING FOCUS ON AUTOMATION TO REDUCE LABOR COSTS
5.2.1.5            INCREASING SPECIALTY DRUG DISPENSING
・     TABLE 3              IMPACT ANALYSIS: MARKET DRIVERS

5.2.2              RESTRAINTS
5.2.2.1            RELUCTANCE TO ADOPT PHARMACY AUTOMATION SYSTEMS
5.2.2.2            HIGH INITIAL CAPITAL INVESTMENTS
5.2.2.3            LACK OF SKILLED PERSONNEL
・     TABLE 4              IMPACT ANALYSIS: MARKET RESTRAINTS
5.2.3              OPPORTUNITIES
5.2.3.1            INCREASING AWARENESS AMONG PHARMACISTS
5.2.3.2            UNTAPPED EMERGING MARKETS
5.2.3.3            HEALTHCARE COST-REDUCTION MEASURES
・     TABLE 5              IMPACT ANALYSIS: MARKET OPPORTUNITIES
5.2.4              CHALLENGES
5.2.4.1            STRINGENT REGULATORY PROCEDURES
5.2.4.2            RISK OF CROSS-CONTAMINATION
・     TABLE 6              IMPACT ANALYSIS: MARKET CHALLENGES
5.3             KEY CONFERENCES & EVENTS
・     TABLE 7              PHARMACY AUTOMATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.4             INDUSTRY TRENDS
5.4.1              SOFTWARE CONFIGURATIONS IN A SMALLER FOOTPRINT
5.4.2              PHARMACY ROBOTICS   54
5.4.3              RADIOFREQUENCY IDENTIFICATION (RFID) IN PHARMACY AUTOMATION
・     TABLE 8              EXAMPLES OF RFID IN PHARMACY AUTOMATION SYSTEMS
5.4.4              ELECTRONIC HEALTH RECORD INTEGRATION AND INTEROPERABILITY THROUGH PHARMACY AUTOMATION SYSTEMS
5.5             PORTER’S FIVE FORCES ANALYSIS
・     TABLE 9              PORTER’S FIVE FORCES ANALYSIS
5.5.1              THREAT FROM NEW ENTRANTS
5.5.2              THREAT FROM SUBSTITUTES
5.5.3              BARGAINING POWER OF SUPPLIERS
5.5.4              BARGAINING POWER OF BUYERS
5.5.5              INTENSITY OF COMPETITIVE RIVALRY
5.6             REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・     TABLE 10            LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7             REGULATORY ANALYSIS
5.7.1              NORTH AMERICA
5.7.1.1            US
5.7.1.2            CANADA
5.7.2              EUROPE
5.7.3              ASIA PACIFIC
5.7.3.1            INDIA
5.7.3.2            AUSTRALIA

5.8             VALUE CHAIN ANALYSIS
・     FIGURE 24          VALUE CHAIN: PHARMACY AUTOMATION MARKET
5.9             TECHNOLOGY ANALYSIS
・     TABLE 11            TECHNOLOGY AND INNOVATION IN THE PHARMACY AUTOMATION MARKET
5.10          PATENT ANALYSIS
5.10.1            PATENT PUBLICATION TRENDS FOR PHARMACY AUTOMATION SYSTEMS
・     FIGURE 25          PATENT PUBLICATION TRENDS (2011–APRIL 2022)
5.10.2            INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
・     FIGURE 26          TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PHARMACY AUTOMATION SYSTEMS (JANUARY 2011–APRIL 2022)
・     FIGURE 27          TOP APPLICANT JURISDICTIONS FOR PHARMACY AUTOMATION SYSTEM PATENTS (JANUARY 2011–APRIL 2022)
・     TABLE 12            LIST OF PATENTS/PATENT APPLICATIONS IN THE PHARMACY AUTOMATION MARKET, 2021–2022
5.11          ECOSYSTEM ANALYSIS
・     FIGURE 28          PHARMACY AUTOMATION MARKET: ECOSYSTEM ANALYSIS
5.12          IMPACT OF COVID-19 ON THE PHARMACY AUTOMATION MARKET

6      PHARMACY AUTOMATION MARKET, BY PRODUCT

6.1             INTRODUCTION
・     TABLE 13            PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
6.2             AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS
・     TABLE 14            POPULAR AUTOMATED MEDICATION DISPENSING SYSTEMS AVAILABLE IN THE MARKET
・     TABLE 15            POPULAR AUTOMATED MEDICATION STORAGE SYSTEMS AVAILABLE IN THE MARKET
・     TABLE 16            AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1              AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS, BY TYPE
・     TABLE 17            AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET,
BY TYPE, 2020–2027 (USD MILLION)
6.2.1.1            ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS
6.2.1.1.1            HIGH ADOPTION OF ROBOTS TO REDUCE DISPENSING ERRORS IN HOSPITALS TO DRIVE MARKET GROWTH
・     TABLE 18            POPULAR ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS AVAILABLE IN THE MARKET
・     TABLE 19            ROBOTS/ROBOTIC AUTOMATED DISPENSING SYSTEMS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2            CAROUSELS
6.2.1.2.1            IMPROVED INVENTORY CONTROL AND WORKFLOW TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
・     TABLE 20            POPULAR CAROUSEL SYSTEMS AVAILABLE IN THE MARKET
・     TABLE 21            CAROUSELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.3            AUTOMATED DISPENSING CABINETS
6.2.1.3.1            SECURED MEDICATION STORAGE AND TRACKING OF DRUGS TO PROPEL THE DEMAND FOR AUTOMATED DISPENSING CABINETS
・     TABLE 22            POPULAR AUTOMATED DISPENSING CABINETS AVAILABLE IN THE MARKET
・     TABLE 23            AUTOMATED DISPENSING CABINETS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2              AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS,
BY APPLICATION/OPERATION
・     TABLE 24            AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET,
BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
6.2.2.1            CENTRALIZED PHARMACIES
6.2.2.1.1            RISING DEMAND FOR CENTRALIZED PHARMACIES TO OPTIMIZE INVENTORY LEVELS AND REDUCE STOCK-OUTS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT  78
・     TABLE 25            CENTRALIZED PHARMACIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.2.2.2            DECENTRALIZED PHARMACIES
6.2.2.2.1            PREFERENCE FOR IMPROVED PATIENT SAFETY TO DRIVE THE MARKET GROWTH   79
・     TABLE 26            DECENTRALIZED PHARMACIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.3             AUTOMATED PACKAGING AND LABELING SYSTEMS
6.3.1              NEED TO IMPROVE DISPENSING ACCURACY AND LOWER THE OVERALL COST IS A MAJOR DRIVER FOR THE AUTOMATED PACKAGING AND LABELING SYSTEMS MARKET
・     TABLE 27            POPULAR AUTOMATED PACKAGING AND LABELING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
・     TABLE 28            AUTOMATED PACKAGING AND LABELING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4             AUTOMATED ・     TABLETOP COUNTERS   82
6.4.1              WITH AN INCREASED NUMBER OF PATIENTS VISITING PHARMACIES, AUTOMATED ・     TABLETOP COUNTERS ARE NEEDED TO BOOST OPERATING SPEEDS
・     TABLE 29            POPULAR AUTOMATED ・     TABLETOP COUNTERS CURRENTLY AVAILABLE IN THE MARKET
・     TABLE 30            AUTOMATED ・     TABLETOP COUNTERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
6.5             AUTOMATED MEDICATION COMPOUNDING SYSTEMS
6.5.1              AUTOMATED MEDICATION COMPOUNDING SYSTEMS REDUCE THE COST PER DOSE OF MEDICATION AND THE NEED FOR MEDICATION OUTSOURCING
・     TABLE 31            POPULAR AUTOMATED COMPOUNDING SYSTEMS CURRENTLY AVAILABLE IN THE MARKET
・     TABLE 32            AUTOMATED MEDICATION COMPOUNDING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6             OTHER PHARMACY AUTOMATION SYSTEMS
・     TABLE 33            OTHER PHARMACY AUTOMATION SYSTEMS MARKET, BY COUNTRY,
2020–2027 (USD MILLION)

7      PHARMACY AUTOMATION MARKET, BY END USER

7.1             INTRODUCTION
・     TABLE 34            PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
7.2             INPATIENT PHARMACIES
・     TABLE 35            PHARMACY AUTOMATION SOLUTIONS USED FOR HOSPITAL INPATIENT PHARMACIES
・     TABLE 36            PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 37            PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1              ACUTE CARE SYSTEMS
7.2.1.1            INCREASING HEALTHCARE SPENDING TO INCREASE THE ADOPTION OF TECHNOLOGY SOLUTIONS IN ACUTE CARE SETTINGS—A KEY FACTOR DRIVING MARKET GROWTH
・     TABLE 38            PHARMACY AUTOMATION MARKET FOR ACUTE CARE SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2              LONG-TERM CARE FACILITIES
7.2.2.1            GROWING GERIATRIC POPULATION TO DRIVE THE ADOPTION OF PHARMACY TECHNOLOGY SOLUTIONS
・     TABLE 39            PHARMACY AUTOMATION SOLUTIONS FOR LONG-TERM CARE FACILITIES
・     TABLE 40            PHARMACY AUTOMATION MARKET FOR LONG-TERM CARE FACILITIES,
BY COUNTRY, 2020–2027 (USD MILLION)
7.3             OUTPATIENT PHARMACIES
・     TABLE 41            PHARMACY AUTOMATION SOLUTIONS USED IN OUTPATIENT PHARMACIES
・     TABLE 42            PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  94
・     TABLE 43            PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY COUNTRY, 2020–2027 (USD MILLION)
7.3.1              OUTPATIENT/FAST-TRACK CLINICS
7.3.1.1            GROWING NEED TO MINIMIZE MEDICATION DISPENSING ERRORS IN OUTPATIENT CLINICS WILL INCREASE THE ADOPTION OF PHARMACY AUTOMATION SYSTEMS
・     TABLE 44            PHARMACY AUTOMATION MARKET FOR OUTPATIENT/FAST-TRACK CLINICS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3.2              HOSPITAL RETAIL SETTINGS
7.3.2.1            NEED FOR ACCURATE MEDICATION DISPENSING AND FASTER INVENTORY MANAGEMENT TO DRIVE MARKET GROWTH
・     TABLE 45            PHARMACY AUTOMATION MARKET FOR HOSPITAL RETAIL SETTINGS,
BY COUNTRY, 2020–2027 (USD MILLION)
7.4             RETAIL PHARMACIES
7.4.1              GROWING NEED FOR TECHNOLOGY TO ASSIST WITH FASTER PRESCRIPTION FILLING AND MEDICATION DISPENSING TO DRIVE MARKET GROWTH
・     TABLE 46            PHARMACY AUTOMATION MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.5             PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES
7.5.1              NEED FOR STREAMLINING PHARMACY OPERATIONS AND ENSURING FASTER WORKFLOWS WILL DRIVE MARKET GROWTH
・     TABLE 47            PHARMACY AUTOMATION SOLUTIONS USED IN MAIL-ORDER PHARMACIES
・     TABLE 48            PHARMACY AUTOMATION MARKET FOR PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS AND MAIL-ORDER PHARMACIES, BY COUNTRY,
2020–2027 (USD MILLION)

8      PHARMACY AUTOMATION MARKET, BY REGION

8.1             INTRODUCTION
・     FIGURE 29          PHARMACY AUTOMATION MARKET: GEOGRAPHIC SNAPSHOT (2021)
・     TABLE 49            PHARMACY AUTOMATION MARKET, BY REGION, 2020–2027 (USD MILLION)
8.2             IMPACT OF COVID-19 ON THE PHARMACY AUTOMATION MARKET, BY COUNTRY/REGION
8.3             NORTH AMERICA
・     FIGURE 30          NORTH AMERICA: PHARMACY AUTOMATION MARKET SNAPSHOT
・     TABLE 50            NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 51            NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 52            NORTH AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 53            NORTH AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION,
2020–2027 (USD MILLION)
・     TABLE 54            NORTH AMERICA: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 55            NORTH AMERICA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 56            NORTH AMERICA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.3.1              US
8.3.1.1            ADVANCED MEDICAL INFRASTRUCTURE AND INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN THE US
・     TABLE 57            US: KEY MACROINDICATORS
・     TABLE 58            US: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 59            US: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)  110
・     TABLE 60            US: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 61            US: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 62            US: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 63            US: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
8.3.2              CANADA
8.3.2.1            GROWING ADOPTION OF TECHNOLOGICALLY ADVANCED HEALTHCARE SOLUTIONS TO PROPEL MARKET GROWTH IN CANADA
・     TABLE 64            CANADA: KEY MACROINDICATORS
・     TABLE 65            CANADA: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 66            CANADA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 67            CANADA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 68            CANADA: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 69            CANADA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  115
・     TABLE 70            CANADA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  115
8.4             EUROPE
・     TABLE 71            EUROPE: PHARMACY AUTOMATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 72            EUROPE: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 73            EUROPE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 74            EUROPE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 75            EUROPE: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 76            EUROPE: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  118
・     TABLE 77            EUROPE: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  118
8.4.1              GERMANY
8.4.1.1            INCREASING HEALTHCARE EXPENDITURE AND GROWING ADOPTION OF HEALTHCARE TECHNOLOGY TO DRIVE MARKET GROWTH IN GERMANY
・     TABLE 78            GERMANY: KEY MACROINDICATORS
・     TABLE 79            GERMANY: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 80            GERMANY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 81            GERMANY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 82            GERMANY: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 83            GERMANY: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  121
・     TABLE 84            GERMANY: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  121
8.4.2              UK

8.4.2.1            RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH IN THE UK   121
・     TABLE 85            UK: KEY MACROINDICATORS
・     TABLE 86            UK: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 87            UK: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)  123
・     TABLE 88            UK: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 89            UK: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 90            UK: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 91            UK: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
8.4.3              FRANCE
8.4.3.1            HIGH HEALTHCARE SPENDING AND FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH IN FRANCE
・     TABLE 92            FRANCE: KEY MACROINDICATORS
・     TABLE 93            FRANCE: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 94            FRANCE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 95            FRANCE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 96            FRANCE: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 97            FRANCE: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  127
・     TABLE 98            FRANCE: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  127
8.4.4              ITALY
8.4.4.1            INITIATIVES TOWARD MEDICAL TECHNOLOGY AND AUTOMATION IMPLEMENTATION TO PROPEL MARKET GROWTH IN ITALY
・     TABLE 99            ITALY: KEY MACROINDICATORS
・     TABLE 100          ITALY: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 101          ITALY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 102          ITALY: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 103          ITALY: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 104          ITALY: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 105          ITALY: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
8.4.5              SPAIN
8.4.5.1            INCREASING FOCUS ON IMPROVING THE HEALTHCARE INFRASTRUCTURE AND GROWING GERIATRIC POPULATION TO SUPPORT THE MARKET GROWTH
・     TABLE 106          SPAIN: KEY MACROINDICATORS   131
・     TABLE 107          SPAIN: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 108          SPAIN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 109          SPAIN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 110          SPAIN: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 111          SPAIN: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 112          SPAIN: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.4.6              REST OF EUROPE
・     TABLE 113          ROE: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 114          ROE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 115          ROE: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 116          ROE: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 117          ROE: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 118          ROE: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
8.5             ASIA PACIFIC
・     FIGURE 31          ASIA PACIFIC: PHARMACY AUTOMATION MARKET SNAPSHOT
・     TABLE 119          ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 120          ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 121          ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)  139
・     TABLE 122          ASIA PACIFIC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION,
2020–2027 (USD MILLION)
・     TABLE 123          ASIA PACIFIC: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 124          ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  140
・     TABLE 125          ASIA PACIFIC: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  140
8.5.1              JAPAN
8.5.1.1            LARGE GERIATRIC POPULATION IN THE COUNTRY DRIVES THE DEMAND FOR PHARMACY AUTOMATED SYSTEMS
・     TABLE 126          JAPAN: KEY MACROINDICATORS   141
・     TABLE 127          JAPAN: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 128          JAPAN: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 129          JAPAN: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 130          JAPAN: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 131          JAPAN: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 132          JAPAN: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.2              CHINA
8.5.2.1            GROWING INVESTMENTS IN HEALTHCARE INFRASTRUCTURE DEVELOPMENT IN CHINA TO DRIVE THE MARKET GROWTH
・     TABLE 133          CHINA: KEY MACROINDICATORS   144
・     TABLE 134          CHINA: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 135          CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 136          CHINA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 137          CHINA: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 138          CHINA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 139          CHINA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.5.3              INDIA
8.5.3.1            INCREASING HEALTHCARE INVESTMENTS WILL BOOST THE DEMAND FOR PHARMACY AUTOMATION SYSTEMS IN INDIA
・     TABLE 140          INDIA: KEY MACROINDICATORS   147
・     TABLE 141          INDIA: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 142          INDIA: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 143          INDIA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 144          INDIA: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 145          INDIA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 146          INDIA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
8.5.4              REST OF ASIA PACIFIC
・     TABLE 147          ROAPAC: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 148          ROAPAC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 149          ROAPAC: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 150          ROAPAC: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 151          ROAPAC: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 152          ROAPAC: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6             LATIN AMERICA
・     TABLE 153          LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY COUNTRY,
2020–2027 (USD MILLION)
・     TABLE 154          LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 155          LATIN AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)  153
・     TABLE 156          LATIN AMERICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION,
2020–2027 (USD MILLION)
・     TABLE 157          LATIN AMERICA: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 158          LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  154
・     TABLE 159          LATIN AMERICA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)  154
8.6.1              BRAZIL
8.6.1.1            BRAZIL ACCOUNTED FOR THE LARGEST SHARE OF THE LATAM MARKET IN 2021
・     TABLE 160          BRAZIL: KEY MACROINDICATORS   155
・     TABLE 161          BRAZIL: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 162          BRAZIL: AUTOMATION MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 163          BRAZIL: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 164          BRAZIL: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 165          BRAZIL: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 166          BRAZIL: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6.2              MEXICO
8.6.2.1            NEED TO REDUCE MEDICATION ERRORS AND THE RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
・     TABLE 167          MEXICO: KEY MACROINDICATORS   158
・     TABLE 168          MEXICO: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 169          MEXICO: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 170          MEXICO: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 171          MEXICO: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 172          MEXICO: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES,
BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 173          MEXICO: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.6.3              REST OF LATIN AMERICA
・     TABLE 174          ROLATAM: PHARMACY AUTOMATION MARKET, BY PRODUCT,
2020–2027 (USD MILLION)
・     TABLE 175          ROLATAM: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)  161
・     TABLE 176          ROLATAM: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION, 2020–2027 (USD MILLION)
・     TABLE 177          ROLATAM: PHARMACY AUTOMATION MARKET, BY END USER,
2020–2027 (USD MILLION)
・     TABLE 178          ROLATAM: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 179          ROLATAM: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
8.7             MIDDLE EAST & AFRICA
8.7.1              IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
・     TABLE 180          SAUDI ARABIA: KEY MACROINDICATORS
・     TABLE 181          SOUTH AFRICA: KEY MACROINDICATORS
・     TABLE 182          MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
・     TABLE 183          MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 184          MIDDLE EAST & AFRICA: AUTOMATED MEDICATION DISPENSING AND STORAGE SYSTEMS MARKET, BY APPLICATION/OPERATION,
2020–2027 (USD MILLION)
・     TABLE 185          MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET, BY END USER, 2020–2027 (USD MILLION)
・     TABLE 186          MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR INPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)
・     TABLE 187          MIDDLE EAST & AFRICA: PHARMACY AUTOMATION MARKET FOR OUTPATIENT PHARMACIES, BY TYPE, 2020–2027 (USD MILLION)

9      COMPETITIVE LANDSCAPE

9.1             OVERVIEW
9.2             KEY PLAYER STRATEGIES/RIGHT TO WIN
・     TABLE 188          OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE PHARMACY AUTOMATION MARKET
9.3             KEY STAKEHOLDERS & BUYING CRITERIA
9.3.1              KEY STAKEHOLDERS IN THE BUYING PROCESS
・     FIGURE 32          INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS
・     TABLE 189          INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS
9.3.2              BUYING CRITERIA   171
・     FIGURE 33          KEY BUYING CRITERIA FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS
・     TABLE 190          KEY BUYING CRITERIA FOR THE TOP 3 PHARMACY AUTOMATION SYSTEMS

9.4             REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
・     FIGURE 34          REVENUE ANALYSIS OF KEY PLAYERS IN THE PHARMACY AUTOMATION MARKET
9.5             MARKET SHARE ANALYSIS
・     FIGURE 35          PHARMACY AUTOMATION MARKET SHARE, BY KEY PLAYER, 2021
・     TABLE 191          PHARMACY AUTOMATION MARKET: DEGREE OF COMPETITION
9.6             COMPETITIVE BENCHMARKING
・     TABLE 192          FOOTPRINT OF COMPANIES IN THE PHARMACY AUTOMATION MARKET
9.6.1              PRODUCT FOOTPRINT  176
・     TABLE 193          PRODUCT FOOTPRINT OF COMPANIES (20 COMPANIES)
9.6.2              END-USER FOOTPRINT
・     TABLE 194          END-USER FOOTPRINT OF COMPANIES (20 COMPANIES)
9.6.3              REGIONAL FOOTPRINT
・     TABLE 195          REGIONAL FOOTPRINT OF COMPANIES (20 COMPANIES)
9.7             COMPETITIVE LEADERSHIP MAPPING
9.7.1              STARS
9.7.2              EMERGING LEADERS   179
9.7.3              PERVASIVE PLAYERS   179
9.7.4              PARTICIPANTS
・     FIGURE 36          PHARMACY AUTOMATION MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
9.8             COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES
9.8.1              PROGRESSIVE COMPANIES
9.8.2              DYNAMIC COMPANIES   181
9.8.3              STARTING BLOCKS   181
9.8.4              RESPONSIVE COMPANIES
・     FIGURE 37          PHARMACY AUTOMATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR OTHER COMPANIES (2021)
9.9             COMPETITIVE SCENARIO
9.9.1              PRODUCT LAUNCHES/UPGRADES
・     TABLE 196          PRODUCT LAUNCHES/APPROVALS/UPGRADES, 2019–2022
9.9.2              DEALS
・     TABLE 197          DEALS, 2019–2022
9.9.3              OTHER DEVELOPMENTS
・     TABLE 198          OTHER DEVELOPMENTS, 2019–2022

10   COMPANY PROFILES

10.1          KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
10.1.1            BECKTON, DICKINSON AND COMPANY
・     TABLE 199          BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
・     FIGURE 38          BECKTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
10.1.2            OMNICELL, INC.
・     TABLE 200          OMNICELL, INC.: BUSINESS OVERVIEW
・     FIGURE 39          OMNICELL, INC.: COMPANY SNAPSHOT (2021)
10.1.3            KUKA AKTIENGESELLSCHAFT (SWISSLOG HEALTHCARE)
・     TABLE 201          KUKA AKTIENGESELLSCHAFT: BUSINESS OVERVIEW
・     FIGURE 40          KUKA AKTIENGESELLSCHAFT: COMPANY SNAPSHOT (2021)
10.1.4            BAXTER INTERNATIONAL INC.
・     TABLE 202          BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
・     FIGURE 41          BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2021)
10.1.5            CAPSA HEALTHCARE   201
・     TABLE 203          CAPSA HEALTHCARE: BUSINESS OVERVIEW
10.1.6            CERNER CORPORATION
・     TABLE 204          CERNER CORPORATION: BUSINESS OVERVIEW
・     FIGURE 42          CERNER CORPORATION: COMPANY SNAPSHOT (2021)
10.1.7            YUYAMA CO., LTD. 207
・     TABLE 205          YUYAMA CO., LTD.: BUSINESS OVERVIEW
10.1.8            ARXIUM, INC.
・     TABLE 206          ARXIUM: BUSINESS OVERVIEW
10.1.9            PARATA SYSTEMS, LLC
・     TABLE 207          PARATA SYSTEMS: BUSINESS OVERVIEW
10.1.10         RXSAFE, LLC
・     TABLE 208          RXSAFE: BUSINESS OVERVIEW
10.1.11         SCRIPTPRO, LLC
・     TABLE 209          SCRIPTPRO, LLC: BUSINESS OVERVIEW
10.1.12         PEARSON MEDICAL TECHNOLOGIES, LLC
・     TABLE 210          PEARSON MEDICAL TECHNOLOGIES, LLC: BUSINESS OVERVIEW
10.1.13         MEDICAL PACKAGING INC., LLC
・     TABLE 211          MEDICAL PACKAGING INC., LLC: BUSINESS OVERVIEW
10.1.14         TENSION CORPORATION
・     TABLE 212          TENSION CORPORATION: BUSINESS OVERVIEW
10.1.15         NORITSU PHARMACY AUTOMATION
・     TABLE 213          NORITSU PHARMACY AUTOMATION: BUSINESS OVERVIEW
10.1.16         EUCLID MEDICAL PRODUCTS
・     TABLE 214          EUCLID MEDICAL PRODUCTS: BUSINESS OVERVIEW
10.1.17         TOUCHPOINT MEDICAL SOLUTIONS
・     TABLE 215          TOUCHPOINT MEDICAL SOLUTIONS: BUSINESS OVERVIEW
10.1.18         MEDITECH PHARMACY MANAGEMENT SOLUTIONS
・     TABLE 216          MEDITECH PHARMACY MANAGEMENT SOLUTIONS: BUSINESS OVERVIEW
10.1.19         INNOVATION ASSOCIATES
・     TABLE 217          INNOVATION ASSOCIATES: BUSINESS OVERVIEW
10.1.20         MCKESSON CORPORATION
・     TABLE 218          MCKESSON CORPORATION: BUSINESS OVERVIEW
・     FIGURE 43          MCKESSON CORPORATION: COMPANY SNAPSHOT (2021)
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
10.2          OTHER PLAYERS
10.2.1            WILLACH GROUP: COMPANY OVERVIEW
10.2.2            STÄUBLI INTERNATIONAL: COMPANY OVERVIEW
10.2.3            MEDAVAIL: COMPANY OVERVIEW
10.2.4            PHARMACY AUTOMATION SYSTEM: COMPANY OVERVIEW
10.2.5            DEENOVA SRL: COMPANY OVERVIEW
11   APPENDIX


△ 一番上に戻る